CALCIUM/CALMODULIN DEPENDENT KINASE 2 SIGNALING PATHWAY (PW:0001185) Description
Calmodulin (CaM), the small and ubiquitous protein expressed from three identical genes in higher organisms, is the main cellular calcium (Ca2+) sensor. Important effectors are the calcium/calmodulin dependent protein kinases (CAMKs) and the only calcium/calmodulin dependent protein phosphatase calcineurin. Some CAMKs have unique targets while others are multifunctional, effectively orchestrating signaling pathways that exert many and important cellular functions. These pathways are represented by CAMK2 signaling and the CAMK1 and CAMK4 cascades. Of these, the CAMK2 exerts a plethora of functions. There are four Camk2 genes - alpha, beta, gamma, delta with distinct expression patterns. Alpha and beta are abundant in the brain while gamma and delta are expressed in many tissues but at comparatively lower levels with delta particularly abundant in the myocardium. The Camk2 signaling plays central roles in excitation-contraction (ECC) and excitation-transcription (E-T) coupling in the heart and in long-term potentiation (LTP) and memory in the brain. Along with the Camk1 cascade, it also plays important roles in cell cycle (not shown). Structurally, all genes are characterized by the presence of N-terminal catalytic domain, the internal regulatory domain that harbors the autoinhibitory segment, the Ca2+/CaM binding site and the critical threonine phosphorylation sites, and the C-terminal association domain also known as the hub; a variable length linker separates the regulatory and the hub regions. The variable length gives rise to more than 30 splice variants in mammals with differing responses to Ca2+ oscillations. The structure of the holoenzyme and of a calmodulin-bound delta isomer have been solved by X-ray crystallography and offer insights into the mechanisms of kinase activation. In the absence of Ca2+/CaM, the autoinhibitory segment forms a helix that block the substrate binding site. There is a compact overall arrangement of the holoenzyme complex; the N-terminal kinase domain is tethered to C-terminal association domain via the regulatory region organizing the protein into ring-shaped hexamers that form the dodecameric structure.
click to access the PDB page . The Ca2+/calmodulin/delta isoform complex contains the catalytic and regulatory domains of the enzyme. Within, the inhibitory region adopts an extended conformation, rather than helical while allowing for the interaction with an adjacent catalytic domain suggestive of an enzyme 'in transit' towards transphosphorylation.
Click to access the PDB page for the calmodulin-bound delta isoform . Binding of Ca2+/CaM displaces the inhibitory segment and the kinase autophosphorylates critical threonine (Thr) residues within the regulatory domain. Phosphorylation of Thr286/287 (286 in alpha, 287 in the other isoforms) dramatically increases the affinity of the kinase for Ca2+CaM and also renders the kinase active even after the Ca2+/Cam has dissociated, hence the autonomous, constitutive activity of Camk2. On the other hand, phosphorylation of Thr305/306 and Thr306/307 interfere with Ca2+CaM binding. These residues are within the Ca2+/CaM binding region; residues 296 and 316 in the enzyme are thought to be involved in the interaction with Ca2+/CaM. The three phosphorylation sites and the regulatory region are invariant across metazoans and there is a high degree of conservation for the hub residues involved in oligomerization. Reactive Oxygen Species (ROS) can activate the kinase in a Ca2+/CaM independent manner by modifying a pair of methionine (Met) residues within the regulatory domain which blocks its re-associatiation with the catalytic domain and preserves the active form of the kinase. The modification is viewed as a marker for oxidative stress and can be reversed by methionine sulfoxide reductases. Dephosphorylation and inactivation of Camk2 is carried out by many phosphatases; the Ca2+/CaM-dependent calcineurin does not directly dephosphorylate Camk2; it acts indirectly by inhibiting an inhibitor of a directly acting phosphatase. Two endogenous inhibitory proteins Camk2n1 and Camk2n2 have been identified in rodent brain and in human dendritic cells. They are specific for the active form of Camk2 and sterically inhibit the kinase; yet, the exact role they exert remains to be established.
In the heart, Camk2 targets many voltage-gated ion channels and excessive activation of the kinase can give rise to arrhythmia. Well established targets include the L-type Ca2+ channel Cacna1c (Cav1.2) and the regulatory beta2 subunit and the sodium channel Scn5a (Nav1.5). The sarcoplasmic reticulum (SR) ryanodine receptor Ryr2 and the regulator of Atp2a2 Ca2+ pump, phospholamban (Pln), are also targets. Camk2 promotes Ca2+ influx and release via Cav1.2 and Ryr2 while promoting Ca2+ uptake via Pln. Pln interacts with the SR pump and inhibits its function; phosphorylation relieves it and renders the pump active. Drugs that target the ion channels have been developed but they have powerful adverse effects. A splice variant of delta gene contains a nuclear localization signal; nuclear targets of Camk2d are histone deacetylases Hdac4 and 5, with the former being the preferred substrate. In the dephosphorylated state, the two bind and repress hypertrophic transcription factors such as Mef2. Phosphorylation relives the repression, allowing for the activation of Mef2-dependent transcription.
The two abundant neuronal subunits of Camk2 are alpha and beta that in addition to homomers, also form heteromers . Activated Camk2 translocates from the cytoplasm to the synapse and interacts with proteins in the postsynaptic density (PSD); a prominent member is Grin2b (NR2B) subtype of ionotropic NMDA receptor. While Camk2 can bind other PSD members, the interaction with Grin2b appears to be crucial for the synaptic translocation of the kinase. This places Camk2 in proximity of ionotropic AMPA receptor Gria1 and stargazin (Cacng2) - a gamma subunit of L-type Ca2+ channel and an auxiliary subunit of AMPA. The phosphorylation of these two substrates enhances the conductance of AMPA receptor and concomitantly leads to the trafficking of additional ones, respectively. These events provide a mechanistic explanation of the early LTP phase. The later phases and LTP maintenance and the exact role Camk2 plays, are far less well understood. Possibly, the binding reactions of Camk2 rather than its catalytic activity are important. Phosphorylation of Thr205/306 may underlie the role of Camk2 in long term depression (LTD), also a feature of the excitatory synapse. To see the ontology report for annotations, Gviewer and download, click here ....(less)
Pathway Diagram:
GO TO:
Genes in Pathway:
Symbol
Object Name
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Cacna1c
calcium voltage-gated channel subunit alpha1 C
ISO
RGD
PMID:23091085
RGD:7240708
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
G
Cacnb2
calcium voltage-gated channel auxiliary subunit beta 2
ISO
RGD
PMID:23091085
RGD:7240708
NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106
G
Cacng2
calcium voltage-gated channel auxiliary subunit gamma 2
ISO
RGD
PMID:22334212
RGD:7240704
NCBI chr 7:109,572,838...109,698,516
Ensembl chr 7:109,574,459...109,697,227
G
Calm1
calmodulin 1
ISO
RGD
PMID:22717267 PMID:23091085
RGD:7240705 , RGD:7240708
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
G
Calm2
calmodulin 2
ISO
RGD
PMID:22717267 PMID:23091085
RGD:7240705 , RGD:7240708
NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287 Ensembl chr15:7,091,567...7,104,287
G
Calm3
calmodulin 3
ISO
RGD
PMID:22717267 PMID:23091085
RGD:7240705 , RGD:7240708
NCBI chr 1:77,590,668...77,597,776
Ensembl chr 1:77,589,230...77,592,207
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
ISO
RGD
PMID:22334212 PMID:22717267
RGD:7240704 , RGD:7240705
NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994
G
Camk2b
calcium/calmodulin-dependent protein kinase II beta
ISO
RGD
PMID:22334212 PMID:22717267
RGD:7240704 , RGD:7240705
NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
G
Camk2d
calcium/calmodulin-dependent protein kinase II delta
ISO
RGD
PMID:22717267 PMID:23091085
RGD:7240705 , RGD:7240708
NCBI chr 2:215,023,785...215,287,351
Ensembl chr 2:215,024,004...215,286,178
G
Camk2g
calcium/calmodulin-dependent protein kinase II gamma
ISO
RGD
PMID:22717267
RGD:7240705
NCBI chr15:3,504,017...3,563,050
Ensembl chr15:3,504,085...3,563,050
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
ISO
RGD
PMID:21070840 PMID:21301225
RGD:7240706 , RGD:7240707
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
G
Camk2n2
calcium/calmodulin-dependent protein kinase II inhibitor 2
ISO
RGD
PMID:21070840 PMID:21301225
RGD:7240706 , RGD:7240707
NCBI chr11:80,289,702...80,290,829
G
Dlg1
discs large MAGUK scaffold protein 1
ISO
RGD
PMID:22717267
RGD:7240705
NCBI chr11:68,911,883...69,103,230
Ensembl chr11:68,911,883...69,102,689
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
ISO
RGD
PMID:22334212
RGD:7240704
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
ISO
RGD
PMID:22717267
RGD:7240705
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Grin2a
glutamate ionotropic receptor NMDA type subunit 2A
ISO
RGD
PMID:22717267
RGD:7240705
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
ISO
RGD
PMID:22334212 PMID:22717267
RGD:7240704 , RGD:7240705
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
G
Hdac4
histone deacetylase 4
ISO
RGD
PMID:21255680
RGD:7241019
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
G
Hdac5
histone deacetylase 5
ISO
RGD
PMID:21255680
RGD:7241019
NCBI chr10:87,152,978...87,187,921
Ensembl chr10:87,152,978...87,188,235
G
Lrrc7
leucine rich repeat containing 7
ISO
RGD
PMID:22717267
RGD:7240705
NCBI chr 2:247,146,616...247,634,945
Ensembl chr 2:247,147,752...247,634,547
G
Pln
phospholamban
ISO
RGD
PMID:23091085
RGD:7240708
NCBI chr20:32,629,537...32,639,559
G
Ppm1e
protein phosphatase, Mg2+/Mn2+ dependent, 1E
ISO
RGD
PMID:18454172
RGD:7241020
NCBI chr10:72,051,643...72,187,439
Ensembl chr10:72,055,208...72,187,282
G
Ppm1f
protein phosphatase, Mg2+/Mn2+ dependent, 1F
TAS
RGD
PMID:18454172
RGD:7241020
NCBI chr11:84,064,422...84,094,410
Ensembl chr11:84,064,420...84,094,340
G
Ppp1cc
protein phosphatase 1 catalytic subunit gamma
ISO
RGD
PMID:18454172
RGD:7241020
NCBI chr12:40,043,822...40,061,301
Ensembl chr12:34,383,072...34,400,553
G
Ppp2ca
protein phosphatase 2 catalytic subunit alpha
TAS
RGD
PMID:18454172
RGD:7241020
NCBI chr10:36,358,110...36,377,864
Ensembl chr10:36,358,101...36,377,862
G
Ryr2
ryanodine receptor 2
ISO
RGD
PMID:23091085
RGD:7240708
NCBI chr17:58,389,925...58,975,641
Ensembl chr17:58,389,925...58,975,142
G
Scn5a
sodium voltage-gated channel alpha subunit 5
ISO
RGD
PMID:23091085
RGD:7240708
NCBI chr 8:119,220,905...119,318,816
Ensembl chr 8:119,220,905...119,318,769
G
Syngap1
synaptic Ras GTPase activating protein 1
ISO
RGD
PMID:22717267
RGD:7240705
NCBI chr20:5,026,366...5,056,659
Ensembl chr20:5,026,364...5,056,672
Additional Elements in Pathway: (includes Gene Groups, Small Molecules, Other Pathways..etc.)
Pathway Gene Annotations
Disease Annotations Associated with Genes in the calcium/calmodulin dependent kinase 2 signaling pathway
Cacna1c acute stress disorder , alcohol dependence , Alzheimer's disease , amyloidosis , anxiety disorder , arrhythmogenic right ventricular cardiomyopathy , autism spectrum disorder , autistic disorder , bipolar disorder , breast ductal carcinoma , Brugada syndrome , Brugada syndrome 3 , Cardiac Arrhythmias , cardiomyopathy , catecholaminergic polymorphic ventricular tachycardia , cerebral palsy , Cognitive Dysfunction , Congenital Limb Deformities , congestive heart failure , dilated cardiomyopathy , epilepsy , esophageal atresia , Familial Ventricular Tachycardia , Fetal Growth Retardation , genetic disease , Genetic Predisposition to Disease , Heart Block , Hyperphosphatemic Familial Tumoral Calcinosis 1 , hypertension , hypertrophic cardiomyopathy , hypertrophic cardiomyopathy 1 , hypoglycemia , intellectual disability , invasive ductal carcinoma , Joint Instability , Language Development Disorders , long QT syndrome , long QT syndrome 1 , long QT syndrome 8 , major depressive disorder , neurodevelopmental disorder with dysmorphic facies and distal limb anomalies , neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures , Neurodevelopmental Disorders , post-traumatic stress disorder , primary immunodeficiency disease , Psychomotor Agitation , restrictive cardiomyopathy , Romano-Ward Syndrome , schizophrenia , short QT syndrome , Sudden Cardiac Death , Sudden Death , Sudden Unexpected Nocturnal Death Syndrome , Timothy syndrome , Tremor , Ventricular Fibrillation, Paroxysmal Familial, 1 , Ventricular Tachycardia , Wolff-Parkinson-White syndrome Cacnb2 arrhythmogenic right ventricular cardiomyopathy , autism spectrum disorder , Brugada syndrome , Brugada syndrome 4 , cardiac arrest , Cardiac Arrhythmias , cardiomyopathy , dilated cardiomyopathy , heart conduction disease , hypertension , hypertrophic cardiomyopathy , hypoparathyroidism-deafness-renal disease syndrome , Imerslund-Grasbeck Syndrome , long QT syndrome , Nerve Injuries , Paroxysmal Ventricular Fibrillation , short QT syndrome , Sudden Death , Sudden Unexpected Nocturnal Death Syndrome , Supraventricular Tachycardia , Ventricular Fibrillation , Ventricular Tachycardia Cacng2 adenylosuccinase lyase deficiency , autosomal dominant intellectual developmental disorder 10 , childhood absence epilepsy , Ependymomas , Neurodevelopmental Disorders Calm1 achondrogenesis type IA , Alzheimer's disease , cannabis abuse , catecholaminergic polymorphic ventricular tachycardia , catecholaminergic polymorphic ventricular tachycardia 1 , catecholaminergic polymorphic ventricular tachycardia 4 , Cocaine-Related Disorders , Familial Ventricular Tachycardia , long QT syndrome , long QT syndrome 14 , phencyclidine abuse , type 2 diabetes mellitus , Weight Gain Calm2 cannabis abuse , Cocaine-Related Disorders , COVID-19 , genetic disease , long QT syndrome , long QT syndrome 1 , long QT syndrome 15 , Lynch syndrome , major depressive disorder , multiple intestinal atresia , phencyclidine abuse , sudden infant death syndrome Calm3 familial hypertrophic cardiomyopathy , long QT syndrome , long QT syndrome 1 , long QT syndrome 16 , Walker-Warburg syndrome Camk2a alcohol use disorder , Alzheimer's disease , autism spectrum disorder , autosomal dominant intellectual developmental disorder 53 , autosomal recessive intellectual developmental disorder 63 , bipolar disorder , Cocaine-Related Disorders , Developmental Disabilities , familial adenomatous polyposis 1 , genetic disease , Hearing Loss, Cisplatin-Induced , Hepatomegaly , Hereditary Neoplastic Syndromes , high grade glioma , Hyperalgesia , Inflammation , intellectual disability , Larsen syndrome , middle cerebral artery infarction , mitochondrial metabolism disease , nephrotoxicity , Neurodevelopmental Disorders , transient cerebral ischemia , Wilson disease Camk2b Apnea , autism spectrum disorder , autosomal dominant intellectual developmental disorder 54 , cannabis abuse , Cocaine-Related Disorders , Developmental Disabilities , Developmental Disease , dystonia , genetic disease , Hearing Loss, Cisplatin-Induced , high grade glioma , Hyperventilation , intellectual disability , microcephaly , Nervous System Malformations , Neurodevelopmental Disorders , oligodendroglioma , phencyclidine abuse , pleomorphic xanthoastrocytoma , schizophrenia , substance-induced psychosis Camk2d aniridia , atrial fibrillation , Cardiomegaly , epilepsy , Experimental Liver Cirrhosis , myocardial infarction , Myocardial Ischemia , Neurodevelopmental Disorders , polycystic ovary syndrome , renovascular hypertension Camk2g autistic disorder , autosomal dominant intellectual developmental disorder 59 , intellectual disability , malignant astrocytoma , Neurodevelopmental Disorders Camk2n1 3-hydroxy-3-methylglutaryl-CoA lyase deficiency , alcohol use disorder , congenital disorder of glycosylation Ir , COVID-19 , Drug-Related Side Effects and Adverse Reactions , hepatocellular carcinoma , hyperprolinemia type 2 , Japanese encephalitis , oral squamous cell carcinoma , ovarian cancer , ovarian carcinoma , papillary thyroid carcinoma , Parkinson's disease 6 , prostate adenocarcinoma , prostate cancer , rabies Camk2n2 3-methylcrotonyl-CoA carboxylase 1 deficiency , congenital disorder of glycosylation Id , Currarino syndrome Dlg1 autistic disorder , cervix uteri carcinoma in situ , chromosome 3q29 microdeletion syndrome , cleft palate , invasive ductal carcinoma , Parkinson's disease , schizophrenia Gria1 alcohol dependence , alcohol use disorder , alcohol withdrawal syndrome , allergic rhinitis , amphetamine abuse , autism spectrum disorder , autistic disorder , autosomal dominant intellectual developmental disorder 67 , autosomal recessive intellectual developmental disorder 76 , Central Nervous System Viral Diseases , cocaine abuse , cocaine dependence , Cocaine-Related Disorders , cognitive disorder , depressive disorder , epilepsy , Experimental Seizures , familial adenomatous polyposis 1 , Fetal Growth Retardation , genetic disease , hepatic encephalopathy , Hereditary Neoplastic Syndromes , heroin dependence , Hyperalgesia , hyperhomocysteinemia , Hyperkinesis , Hypotension , intellectual disability , learning disability , morphine dependence , morphine withdrawal syndrome , Neurodevelopmental Disorders , non-syndromic intellectual disability , Olfaction Disorders , Prenatal Exposure Delayed Effects , Reperfusion Injury , schizoaffective disorder , sexual health disorder , status epilepticus , traumatic brain injury , withdrawal disorder Grin1 Adams-Oliver Syndrome 5 , alcohol use disorder , Alzheimer's disease , Animal Disease Models , autism spectrum disorder , autistic disorder , autosomal dominant intellectual developmental disorder 8 , autosomal dominant nocturnal frontal lobe epilepsy 5 , benign epilepsy with centrotemporal spikes , Brain Hypoxia-Ischemia , cerebral infarction , Cocaine-Related Disorders , cognitive disorder , developmental and epileptic encephalopathy 1 , developmental and epileptic encephalopathy 101 , developmental and epileptic encephalopathy 14 , epilepsy , Experimental Diabetes Mellitus , genetic disease , Hemimegalencephaly , Hyperalgesia , intellectual disability , Joubert syndrome 1 , Kleefstra syndrome 1 , Leigh disease , middle cerebral artery infarction , morphine dependence , Neurodevelopmental Disorder with or without Hyperkinetic Movements and Seizures, Autosomal Recessive , Neurodevelopmental Disorders , opioid abuse , Pain , placental insufficiency , primary coenzyme Q10 deficiency 7 , prostate cancer , psychotic disorder , Rafiq syndrome , schizophrenia , sciatic neuropathy , status epilepticus , trigeminal neuralgia , tuberous sclerosis 1 , vascular dementia Grin2a alcohol dependence , Alzheimer's disease , autistic disorder , autosomal dominant intellectual developmental disorder 21 , benign epilepsy with centrotemporal spikes , bipolar disorder , Brain Hypoxia-Ischemia , Central Nervous System Viral Diseases , Charcot-Marie-Tooth disease type 1C , cognitive disorder , colorectal cancer , Colorectal Neoplasms , developmental and epileptic encephalopathy 11 , Developmental Disabilities , epilepsy , familial temporal lobe epilepsy 1 , Fetal Growth Retardation , focal epilepsy , Focal Epilepsy with Speech Disorder and with or without Mental Retardation , GABA aminotransferase deficiency , generalized epilepsy , genetic disease , heroin dependence , Huntington's disease , Hyperalgesia , hyperhomocysteinemia , intellectual disability , Landau-Kleffner syndrome , Language Development Disorders , melanoma , MHC class II deficiency , microcephaly , morphine dependence , nasopharynx carcinoma , neonatal abstinence syndrome , Neuralgia , NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES , Neurodevelopmental Disorders , opioid abuse , placental insufficiency , post-traumatic stress disorder , pyridoxine-dependent epilepsy , Reperfusion Injury , schizophrenia , Sepsis , speech disorder , status epilepticus , Tinnitus , transient cerebral ischemia , vascular dementia , withdrawal disorder Grin2b alcohol use disorder , Alzheimer's disease , astigmatism , Ataxia , attention deficit hyperactivity disorder , autism spectrum disorder , autistic disorder , autosomal dominant intellectual developmental disorder , autosomal dominant intellectual developmental disorder 6 , bipolar disorder , Brain Hypoxia-Ischemia , cannabis abuse , cerebral palsy , chronic obstructive pulmonary disease , cognitive disorder , Craniosynostosis Syndrome, Autosomal Recessive , developmental and epileptic encephalopathy 11 , developmental and epileptic encephalopathy 27 , Developmental Disabilities , Developmental Disease , dystonia , egg allergy , epilepsy , Experimental Diabetes Mellitus , fetal alcohol spectrum disorder , Fetal Growth Retardation , generalized epilepsy , genetic disease , heroin dependence , Huntington's disease , Hyperalgesia , hyperhomocysteinemia , hypoglycemia , Hypotension , Hypoxia , intellectual disability , Landau-Kleffner syndrome , Nervous System Trauma , Neurodevelopmental Disorders , nicotine dependence , opioid abuse , phenylketonuria , placental insufficiency , Reperfusion Injury , retinitis pigmentosa , schizophrenia , sciatic neuropathy , Sleep Deprivation , temporal lobe epilepsy , transient cerebral ischemia , vascular dementia , withdrawal disorder Hdac4 acute lymphoblastic leukemia , amyotrophic lateral sclerosis , aortic aneurysm , ataxia telangiectasia , atherosclerosis , Bethlem Myopathy 1A , brachydactyly , brachydactyly type E1 , Brachydactyly, Type E , Carotid Artery Injuries , chromosome 2q37 deletion syndrome , Cocaine-Related Disorders , contact dermatitis , D-2-hydroxyglutaric aciduria 1 , Diabetes Complications , Diabetic Nephropathies , eating disorder , epilepsy , Experimental Diabetes Mellitus , fetal alcohol spectrum disorder , Fibrosis , genetic disease , hepatocellular carcinoma , hereditary spastic paraplegia 30 , Hypoalgesia , impotence , intellectual disability , malignant mesothelioma , microcephaly , middle cerebral artery infarction , multiple myeloma , NEURODEVELOPMENTAL DISORDER WITH CENTRAL HYPOTONIA AND DYSMORPHIC FACIES , Neurodevelopmental Disorders , obesity , primary hyperoxaluria type 1 , primary pulmonary hypertension , pulmonary hypertension , retinal degeneration , Sepsis , spinal muscular atrophy , Stroke , syndromic intellectual disability , urinary bladder cancer Hdac5 acute kidney failure , adjustment disorder , bipolar disorder , Cocaine-Related Disorders , colorectal cancer , depressive disorder , Diabetic Nephropathies , GRN-related frontotemporal lobar degeneration with TDP43 inclusions , hereditary breast ovarian cancer syndrome , middle cerebral artery infarction , primary pulmonary hypertension , pulmonary hypertension , Right Ventricular Hypertrophy , systemic scleroderma , transient cerebral ischemia Lrrc7 cocaine dependence , Cocaine-Related Disorders , intellectual disability Pln atrial fibrillation , autistic disorder , cardiac arrest , cardiomyopathy , centronuclear myopathy , congenital disorder of glycosylation Iaa , congestive heart failure , Diabetes Complications , Diabetic Cardiomyopathies , dilated cardiomyopathy , dilated cardiomyopathy 1P , Ebstein anomaly , heart disease , hypertrophic cardiomyopathy , hypertrophic cardiomyopathy 18 , intellectual disability , intrinsic cardiomyopathy , lissencephaly 10 , microcephaly , myocardial infarction , Myocardial Reperfusion Injury , myocardial stunning , Prehypertension , Sudden Cardiac Death , Tremor , type 2 diabetes mellitus , Ventricular Dysfunction, Left Ppm1e Colorectal Neoplasms , Joubert syndrome 1 , mulibrey nanism Ppm1f chromosome 22q11.2 deletion syndrome, distal , DiGeorge syndrome Ppp1cc congestive heart failure , Ovarian Neoplasms , Spinal Cord Injuries Ppp2ca asthma , congestive heart failure , Experimental Liver Neoplasms , familial adenomatous polyposis 1 , genetic disease , heart disease , Hereditary Neoplastic Syndromes , Hyperalgesia , Myocardial Ischemia , Neurodevelopmental Disorder and Language Delay with or Without Structural Brain Abnormalities , Neurodevelopmental Disorders , Parkinson's disease , prostate cancer , type 2 diabetes mellitus Ryr2 arrhythmogenic right ventricular cardiomyopathy , arrhythmogenic right ventricular dysplasia 1 , arrhythmogenic right ventricular dysplasia 9 , autism spectrum disorder , Brugada syndrome , cardiac arrest , Cardiac Arrhythmias , Cardiac Conduction Defect , cardiomyopathy , catecholaminergic polymorphic ventricular tachycardia , catecholaminergic polymorphic ventricular tachycardia 1 , catecholaminergic polymorphic ventricular tachycardia 2 , Childhood Schizophrenia , congenital heart disease , congestive heart failure , coronary artery disease , Diabetic Cardiomyopathies , Diastolic Dysfunction , dilated cardiomyopathy , dilated cardiomyopathy 1AA , dilated cardiomyopathy 1B , dilated cardiomyopathy 1C , Dilated Cardiomyopathy with Left Ventricular Noncompaction , Experimental Diabetes Mellitus , familial hypertrophic cardiomyopathy , Familial Sudden Death , Familial Ventricular Tachycardia , gastrointestinal stromal tumor , gestational diabetes , Heart Block , heart disease , Hereditary Leiomyomatosis and Renal Cell Cancer , hypertrophic cardiomyopathy , hypertrophic cardiomyopathy 1 , hypertrophic cardiomyopathy 4 , Infant Death , left ventricular noncompaction , long QT syndrome , long QT syndrome 1 , malignant mesothelioma , microcephalic osteodysplastic primordial dwarfism type I , Microcephalic Osteodysplastic Primordial Dwarfism, Type III , Myocardial Ischemia , parathyroid carcinoma , Paroxysmal Ventricular Fibrillation , pre-eclampsia , pulmonary hypertension , Sudden Cardiac Death , Sudden Death , Syncope , Tachycardia , Ventricular Fibrillation , Ventricular Fibrillation, Paroxysmal Familial, 1 , Ventricular Tachycardia , Wolff-Parkinson-White syndrome Scn5a arrhythmogenic right ventricular cardiomyopathy , atrial fibrillation , atrial standstill 1 , atrioventricular block , autistic disorder , brain ischemia , Brugada syndrome , Brugada syndrome 1 , cardiac arrest , Cardiac Arrhythmias , Cardiac Conduction Defect , Cardiac Conduction Defect, Nonprogressive , Cardiac Conduction Defect, Nonspecific , cardiomyopathy , catecholaminergic polymorphic ventricular tachycardia , catecholaminergic polymorphic ventricular tachycardia 1 , congestive heart failure , Death , dilated cardiomyopathy , dilated cardiomyopathy 1A , dilated cardiomyopathy 1B , dilated cardiomyopathy 1E , Dilated Cardiomyopathy with Left Ventricular Noncompaction , Familial Atrial Fibrillation 10 , familial hypertrophic cardiomyopathy , fetal akinesia deformation sequence syndrome 1 , genetic disease , Heart Block , heart conduction disease , hemiplegia , hereditary sensory and autonomic neuropathy type 7 , hypertrophic cardiomyopathy , hypertrophic cardiomyopathy 1 , Immunodeficiency 68 , Infant Death , Left Ventricular Noncompaction 1 , long QT syndrome , long QT syndrome 1 , long QT syndrome 2 , Long QT Syndrome 2/3 , long QT syndrome 3 , Long QT Syndrome 3/6 , migraine , Nonprogressive Heart Block , Paroxysmal Ventricular Fibrillation , progressive familial heart block , Progressive Familial Heart Block Type I , progressive familial heart block type IA , Romano-Ward Syndrome , sick sinus syndrome , Sick Sinus Syndrome 1, Autosomal Recessive , sinoatrial node disease , Sudden Cardiac Death , Sudden Death , sudden infant death syndrome , Sudden Unexpected Nocturnal Death Syndrome , Syncope , Torsades de Pointes , Ventricular Fibrillation , Ventricular Fibrillation, Paroxysmal Familial, 1 , Ventricular Tachycardia , visceral heterotaxy 4 , Wolff-Parkinson-White syndrome Syngap1 autistic disorder , autosomal dominant intellectual developmental disorder 5 , autosomal dominant nocturnal frontal lobe epilepsy , autosomal recessive intellectual developmental disorder 5 , cerebellar ataxia , developmental and epileptic encephalopathy 11 , Developmental Disabilities , Developmental Disease , epilepsy , generalized epilepsy , genetic disease , intellectual disability , Marfanoid Mental Retardation Syndrome, Autosomal , MHC class I deficiency , Neurodevelopmental Disorders , proteasome-associated autoinflammatory syndrome 1 , ptosis , salt and pepper syndrome , schizophrenia
3-hydroxy-3-methylglutaryl-CoA lyase deficiency Camk2n1 3-methylcrotonyl-CoA carboxylase 1 deficiency Camk2n2 achondrogenesis type IA Calm1 acute kidney failure Hdac5 acute lymphoblastic leukemia Hdac4 acute stress disorder Cacna1c Adams-Oliver Syndrome 5 Grin1 adenylosuccinase lyase deficiency Cacng2 adjustment disorder Hdac5 alcohol dependence Cacna1c , Gria1 , Grin2a alcohol use disorder Camk2a , Camk2n1 , Gria1 , Grin1 , Grin2b alcohol withdrawal syndrome Gria1 allergic rhinitis Gria1 Alzheimer's disease Cacna1c , Calm1 , Camk2a , Grin1 , Grin2a , Grin2b amphetamine abuse Gria1 amyloidosis Cacna1c amyotrophic lateral sclerosis Hdac4 Animal Disease Models Grin1 aniridia Camk2d anxiety disorder Cacna1c aortic aneurysm Hdac4 Apnea Camk2b arrhythmogenic right ventricular cardiomyopathy Cacna1c , Cacnb2 , Ryr2 , Scn5a arrhythmogenic right ventricular dysplasia 1 Ryr2 arrhythmogenic right ventricular dysplasia 9 Ryr2 asthma Ppp2ca astigmatism Grin2b Ataxia Grin2b ataxia telangiectasia Hdac4 atherosclerosis Hdac4 atrial fibrillation Camk2d , Pln , Scn5a atrial standstill 1 Scn5a atrioventricular block Scn5a attention deficit hyperactivity disorder Grin2b autism spectrum disorder Cacna1c , Cacnb2 , Camk2a , Camk2b , Gria1 , Grin1 , Grin2b , Ryr2 autistic disorder Cacna1c , Camk2g , Dlg1 , Gria1 , Grin1 , Grin2a , Grin2b , Pln , Scn5a , Syngap1 autosomal dominant intellectual developmental disorder Grin2b autosomal dominant intellectual developmental disorder 10 Cacng2 autosomal dominant intellectual developmental disorder 21 Grin2a autosomal dominant intellectual developmental disorder 5 Syngap1 autosomal dominant intellectual developmental disorder 53 Camk2a autosomal dominant intellectual developmental disorder 54 Camk2b autosomal dominant intellectual developmental disorder 59 Camk2g autosomal dominant intellectual developmental disorder 6 Grin2b autosomal dominant intellectual developmental disorder 67 Gria1 autosomal dominant intellectual developmental disorder 8 Grin1 autosomal dominant nocturnal frontal lobe epilepsy Syngap1 autosomal dominant nocturnal frontal lobe epilepsy 5 Grin1 autosomal recessive intellectual developmental disorder 5 Syngap1 autosomal recessive intellectual developmental disorder 63 Camk2a autosomal recessive intellectual developmental disorder 76 Gria1 benign epilepsy with centrotemporal spikes Grin1 , Grin2a Bethlem Myopathy 1A Hdac4 bipolar disorder Cacna1c , Camk2a , Grin2a , Grin2b , Hdac5 brachydactyly Hdac4 brachydactyly type E1 Hdac4 Brachydactyly, Type E Hdac4 Brain Hypoxia-Ischemia Grin1 , Grin2a , Grin2b brain ischemia Scn5a breast ductal carcinoma Cacna1c Brugada syndrome Cacna1c , Cacnb2 , Ryr2 , Scn5a Brugada syndrome 1 Scn5a Brugada syndrome 3 Cacna1c Brugada syndrome 4 Cacnb2 cannabis abuse Calm1 , Calm2 , Camk2b , Grin2b cardiac arrest Cacnb2 , Pln , Ryr2 , Scn5a Cardiac Arrhythmias Cacna1c , Cacnb2 , Ryr2 , Scn5a Cardiac Conduction Defect Ryr2 , Scn5a Cardiac Conduction Defect, Nonprogressive Scn5a Cardiac Conduction Defect, Nonspecific Scn5a Cardiomegaly Camk2d cardiomyopathy Cacna1c , Cacnb2 , Pln , Ryr2 , Scn5a Carotid Artery Injuries Hdac4 catecholaminergic polymorphic ventricular tachycardia Cacna1c , Calm1 , Ryr2 , Scn5a catecholaminergic polymorphic ventricular tachycardia 1 Calm1 , Ryr2 , Scn5a catecholaminergic polymorphic ventricular tachycardia 2 Ryr2 catecholaminergic polymorphic ventricular tachycardia 4 Calm1 Central Nervous System Viral Diseases Gria1 , Grin2a centronuclear myopathy Pln cerebellar ataxia Syngap1 cerebral infarction Grin1 cerebral palsy Cacna1c , Grin2b cervix uteri carcinoma in situ Dlg1 Charcot-Marie-Tooth disease type 1C Grin2a childhood absence epilepsy Cacng2 Childhood Schizophrenia Ryr2 chromosome 22q11.2 deletion syndrome, distal Ppm1f chromosome 2q37 deletion syndrome Hdac4 chromosome 3q29 microdeletion syndrome Dlg1 chronic obstructive pulmonary disease Grin2b cleft palate Dlg1 cocaine abuse Gria1 cocaine dependence Gria1 , Lrrc7 Cocaine-Related Disorders Calm1 , Calm2 , Camk2a , Camk2b , Gria1 , Grin1 , Hdac4 , Hdac5 , Lrrc7 cognitive disorder Gria1 , Grin1 , Grin2a , Grin2b Cognitive Dysfunction Cacna1c colorectal cancer Grin2a , Hdac5 Colorectal Neoplasms Grin2a , Ppm1e congenital disorder of glycosylation Iaa Pln congenital disorder of glycosylation Id Camk2n2 congenital disorder of glycosylation Ir Camk2n1 congenital heart disease Ryr2 Congenital Limb Deformities Cacna1c congestive heart failure Cacna1c , Pln , Ppp1cc , Ppp2ca , Ryr2 , Scn5a contact dermatitis Hdac4 coronary artery disease Ryr2 COVID-19 Calm2 , Camk2n1 Craniosynostosis Syndrome, Autosomal Recessive Grin2b Currarino syndrome Camk2n2 D-2-hydroxyglutaric aciduria 1 Hdac4 Death Scn5a depressive disorder Gria1 , Hdac5 developmental and epileptic encephalopathy 1 Grin1 developmental and epileptic encephalopathy 101 Grin1 developmental and epileptic encephalopathy 11 Grin2a , Grin2b , Syngap1 developmental and epileptic encephalopathy 14 Grin1 developmental and epileptic encephalopathy 27 Grin2b Developmental Disabilities Camk2a , Camk2b , Grin2a , Grin2b , Syngap1 Developmental Disease Camk2b , Grin2b , Syngap1 Diabetes Complications Hdac4 , Pln Diabetic Cardiomyopathies Pln , Ryr2 Diabetic Nephropathies Hdac4 , Hdac5 Diastolic Dysfunction Ryr2 DiGeorge syndrome Ppm1f dilated cardiomyopathy Cacna1c , Cacnb2 , Pln , Ryr2 , Scn5a dilated cardiomyopathy 1A Scn5a dilated cardiomyopathy 1AA Ryr2 dilated cardiomyopathy 1B Ryr2 , Scn5a dilated cardiomyopathy 1C Ryr2 dilated cardiomyopathy 1E Scn5a dilated cardiomyopathy 1P Pln Dilated Cardiomyopathy with Left Ventricular Noncompaction Ryr2 , Scn5a Drug-Related Side Effects and Adverse Reactions Camk2n1 dystonia Camk2b , Grin2b eating disorder Hdac4 Ebstein anomaly Pln egg allergy Grin2b Ependymomas Cacng2 epilepsy Cacna1c , Camk2d , Gria1 , Grin1 , Grin2a , Grin2b , Hdac4 , Syngap1 esophageal atresia Cacna1c Experimental Diabetes Mellitus Grin1 , Grin2b , Hdac4 , Ryr2 Experimental Liver Cirrhosis Camk2d Experimental Liver Neoplasms Ppp2ca Experimental Seizures Gria1 familial adenomatous polyposis 1 Camk2a , Gria1 , Ppp2ca Familial Atrial Fibrillation 10 Scn5a familial hypertrophic cardiomyopathy Calm3 , Ryr2 , Scn5a Familial Sudden Death Ryr2 familial temporal lobe epilepsy 1 Grin2a Familial Ventricular Tachycardia Cacna1c , Calm1 , Ryr2 fetal akinesia deformation sequence syndrome 1 Scn5a fetal alcohol spectrum disorder Grin2b , Hdac4 Fetal Growth Retardation Cacna1c , Gria1 , Grin2a , Grin2b Fibrosis Hdac4 focal epilepsy Grin2a Focal Epilepsy with Speech Disorder and with or without Mental Retardation Grin2a GABA aminotransferase deficiency Grin2a gastrointestinal stromal tumor Ryr2 generalized epilepsy Grin2a , Grin2b , Syngap1 genetic disease Cacna1c , Calm2 , Camk2a , Camk2b , Gria1 , Grin1 , Grin2a , Grin2b , Hdac4 , Ppp2ca , Scn5a , Syngap1 Genetic Predisposition to Disease Cacna1c gestational diabetes Ryr2 GRN-related frontotemporal lobar degeneration with TDP43 inclusions Hdac5 Hearing Loss, Cisplatin-Induced Camk2a , Camk2b Heart Block Cacna1c , Ryr2 , Scn5a heart conduction disease Cacnb2 , Scn5a heart disease Pln , Ppp2ca , Ryr2 Hemimegalencephaly Grin1 hemiplegia Scn5a hepatic encephalopathy Gria1 hepatocellular carcinoma Camk2n1 , Hdac4 Hepatomegaly Camk2a hereditary breast ovarian cancer syndrome Hdac5 Hereditary Leiomyomatosis and Renal Cell Cancer Ryr2 Hereditary Neoplastic Syndromes Camk2a , Gria1 , Ppp2ca hereditary sensory and autonomic neuropathy type 7 Scn5a hereditary spastic paraplegia 30 Hdac4 heroin dependence Gria1 , Grin2a , Grin2b high grade glioma Camk2a , Camk2b Huntington's disease Grin2a , Grin2b Hyperalgesia Camk2a , Gria1 , Grin1 , Grin2a , Grin2b , Ppp2ca hyperhomocysteinemia Gria1 , Grin2a , Grin2b Hyperkinesis Gria1 Hyperphosphatemic Familial Tumoral Calcinosis 1 Cacna1c hyperprolinemia type 2 Camk2n1 hypertension Cacna1c , Cacnb2 hypertrophic cardiomyopathy Cacna1c , Cacnb2 , Pln , Ryr2 , Scn5a hypertrophic cardiomyopathy 1 Cacna1c , Ryr2 , Scn5a hypertrophic cardiomyopathy 18 Pln hypertrophic cardiomyopathy 4 Ryr2 Hyperventilation Camk2b Hypoalgesia Hdac4 hypoglycemia Cacna1c , Grin2b hypoparathyroidism-deafness-renal disease syndrome Cacnb2 Hypotension Gria1 , Grin2b Hypoxia Grin2b Imerslund-Grasbeck Syndrome Cacnb2 Immunodeficiency 68 Scn5a impotence Hdac4 Infant Death Ryr2 , Scn5a Inflammation Camk2a intellectual disability Cacna1c , Camk2a , Camk2b , Camk2g , Gria1 , Grin1 , Grin2a , Grin2b , Hdac4 , Lrrc7 , Pln , Syngap1 intrinsic cardiomyopathy Pln invasive ductal carcinoma Cacna1c , Dlg1 Japanese encephalitis Camk2n1 Joint Instability Cacna1c Joubert syndrome 1 Grin1 , Ppm1e Kleefstra syndrome 1 Grin1 Landau-Kleffner syndrome Grin2a , Grin2b Language Development Disorders Cacna1c , Grin2a Larsen syndrome Camk2a learning disability Gria1 left ventricular noncompaction Ryr2 Left Ventricular Noncompaction 1 Scn5a Leigh disease Grin1 lissencephaly 10 Pln long QT syndrome Cacna1c , Cacnb2 , Calm1 , Calm2 , Calm3 , Ryr2 , Scn5a long QT syndrome 1 Cacna1c , Calm2 , Calm3 , Ryr2 , Scn5a long QT syndrome 14 Calm1 long QT syndrome 15 Calm2 long QT syndrome 16 Calm3 long QT syndrome 2 Scn5a Long QT Syndrome 2/3 Scn5a long QT syndrome 3 Scn5a Long QT Syndrome 3/6 Scn5a long QT syndrome 8 Cacna1c Lynch syndrome Calm2 major depressive disorder Cacna1c , Calm2 malignant astrocytoma Camk2g malignant mesothelioma Hdac4 , Ryr2 Marfanoid Mental Retardation Syndrome, Autosomal Syngap1 melanoma Grin2a MHC class I deficiency Syngap1 MHC class II deficiency Grin2a microcephalic osteodysplastic primordial dwarfism type I Ryr2 Microcephalic Osteodysplastic Primordial Dwarfism, Type III Ryr2 microcephaly Camk2b , Grin2a , Hdac4 , Pln middle cerebral artery infarction Camk2a , Grin1 , Hdac4 , Hdac5 migraine Scn5a mitochondrial metabolism disease Camk2a morphine dependence Gria1 , Grin1 , Grin2a morphine withdrawal syndrome Gria1 mulibrey nanism Ppm1e multiple intestinal atresia Calm2 multiple myeloma Hdac4 myocardial infarction Camk2d , Pln Myocardial Ischemia Camk2d , Ppp2ca , Ryr2 Myocardial Reperfusion Injury Pln myocardial stunning Pln nasopharynx carcinoma Grin2a neonatal abstinence syndrome Grin2a nephrotoxicity Camk2a Nerve Injuries Cacnb2 Nervous System Malformations Camk2b Nervous System Trauma Grin2b Neuralgia Grin2a Neurodevelopmental Disorder and Language Delay with or Without Structural Brain Abnormalities Ppp2ca NEURODEVELOPMENTAL DISORDER WITH CENTRAL HYPOTONIA AND DYSMORPHIC FACIES Hdac4 neurodevelopmental disorder with dysmorphic facies and distal limb anomalies Cacna1c neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures Cacna1c NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES Grin2a Neurodevelopmental Disorder with or without Hyperkinetic Movements and Seizures, Autosomal Recessive Grin1 Neurodevelopmental Disorders Cacna1c , Cacng2 , Camk2a , Camk2b , Camk2d , Camk2g , Gria1 , Grin1 , Grin2a , Grin2b , Hdac4 , Ppp2ca , Syngap1 nicotine dependence Grin2b non-syndromic intellectual disability Gria1 Nonprogressive Heart Block Scn5a obesity Hdac4 Olfaction Disorders Gria1 oligodendroglioma Camk2b opioid abuse Grin1 , Grin2a , Grin2b oral squamous cell carcinoma Camk2n1 ovarian cancer Camk2n1 ovarian carcinoma Camk2n1 Ovarian Neoplasms Ppp1cc Pain Grin1 papillary thyroid carcinoma Camk2n1 parathyroid carcinoma Ryr2 Parkinson's disease Dlg1 , Ppp2ca Parkinson's disease 6 Camk2n1 Paroxysmal Ventricular Fibrillation Cacnb2 , Ryr2 , Scn5a phencyclidine abuse Calm1 , Calm2 , Camk2b phenylketonuria Grin2b placental insufficiency Grin1 , Grin2a , Grin2b pleomorphic xanthoastrocytoma Camk2b polycystic ovary syndrome Camk2d post-traumatic stress disorder Cacna1c , Grin2a pre-eclampsia Ryr2 Prehypertension Pln Prenatal Exposure Delayed Effects Gria1 primary coenzyme Q10 deficiency 7 Grin1 primary hyperoxaluria type 1 Hdac4 primary immunodeficiency disease Cacna1c primary pulmonary hypertension Hdac4 , Hdac5 progressive familial heart block Scn5a Progressive Familial Heart Block Type I Scn5a progressive familial heart block type IA Scn5a prostate adenocarcinoma Camk2n1 prostate cancer Camk2n1 , Grin1 , Ppp2ca proteasome-associated autoinflammatory syndrome 1 Syngap1 Psychomotor Agitation Cacna1c psychotic disorder Grin1 ptosis Syngap1 pulmonary hypertension Hdac4 , Hdac5 , Ryr2 pyridoxine-dependent epilepsy Grin2a rabies Camk2n1 Rafiq syndrome Grin1 renovascular hypertension Camk2d Reperfusion Injury Gria1 , Grin2a , Grin2b restrictive cardiomyopathy Cacna1c retinal degeneration Hdac4 retinitis pigmentosa Grin2b Right Ventricular Hypertrophy Hdac5 Romano-Ward Syndrome Cacna1c , Scn5a salt and pepper syndrome Syngap1 schizoaffective disorder Gria1 schizophrenia Cacna1c , Camk2b , Dlg1 , Grin1 , Grin2a , Grin2b , Syngap1 sciatic neuropathy Grin1 , Grin2b Sepsis Grin2a , Hdac4 sexual health disorder Gria1 short QT syndrome Cacna1c , Cacnb2 sick sinus syndrome Scn5a Sick Sinus Syndrome 1, Autosomal Recessive Scn5a sinoatrial node disease Scn5a Sleep Deprivation Grin2b speech disorder Grin2a Spinal Cord Injuries Ppp1cc spinal muscular atrophy Hdac4 status epilepticus Gria1 , Grin1 , Grin2a Stroke Hdac4 substance-induced psychosis Camk2b Sudden Cardiac Death Cacna1c , Pln , Ryr2 , Scn5a Sudden Death Cacna1c , Cacnb2 , Ryr2 , Scn5a sudden infant death syndrome Calm2 , Scn5a Sudden Unexpected Nocturnal Death Syndrome Cacna1c , Cacnb2 , Scn5a Supraventricular Tachycardia Cacnb2 Syncope Ryr2 , Scn5a syndromic intellectual disability Hdac4 systemic scleroderma Hdac5 Tachycardia Ryr2 temporal lobe epilepsy Grin2b Timothy syndrome Cacna1c Tinnitus Grin2a Torsades de Pointes Scn5a transient cerebral ischemia Camk2a , Grin2a , Grin2b , Hdac5 traumatic brain injury Gria1 Tremor Cacna1c , Pln trigeminal neuralgia Grin1 tuberous sclerosis 1 Grin1 type 2 diabetes mellitus Calm1 , Pln , Ppp2ca urinary bladder cancer Hdac4 vascular dementia Grin1 , Grin2a , Grin2b Ventricular Dysfunction, Left Pln Ventricular Fibrillation Cacnb2 , Ryr2 , Scn5a Ventricular Fibrillation, Paroxysmal Familial, 1 Cacna1c , Ryr2 , Scn5a Ventricular Tachycardia Cacna1c , Cacnb2 , Ryr2 , Scn5a visceral heterotaxy 4 Scn5a Walker-Warburg syndrome Calm3 Weight Gain Calm1 Wilson disease Camk2a withdrawal disorder Gria1 , Grin2a , Grin2b Wolff-Parkinson-White syndrome Cacna1c , Ryr2 , Scn5a
Pathway Annotations Associated with Genes in the calcium/calmodulin dependent kinase 2 signaling pathway
Cacna1c acebutolol pharmacodynamics pathway , adrenergic beta receptor agonist and beta-blocker pharmacodynamics pathway , Alzheimer's disease pathway , amiodarone pharmacodynamics pathway , amlodipine pharmacodynamics pathway , arrhythmogenic right ventricular cardiomyopathy pathway , atenolol pharmacodynamics pathway , betaxolol pharmacodynamics pathway , bisoprolol pharmacodynamics pathway , bupranolol drug pathway , bupranolol pharmacodynamics pathway , calcium transport pathway , calcium/calcium-mediated signaling pathway , calcium/calmodulin dependent kinase 2 signaling pathway , carvedilol pharmacodynamics pathway , dilated cardiomyopathy pathway , diltiazem pharmacodynamics pathway , disopyramide pharmacodynamics pathway , dobutamine pharmacodynamics pathway , esmolol pharmacodynamics pathway , felodipine pharmacokinetics pathway , flecainde pharmacodynamics pathway , fosphenytoin pharmacodynamics pathway , glutamate signaling pathway , gonadotropin-releasing hormone signaling pathway , hypertrophic cardiomyopathy pathway , ibutilide pharmacodynamics pathway , insulin secretion pathway , isoprenaline pharmacodynamics pathway , isradipine pharmacodynamics pathway , levobunolol pharmacodynamics pathway , lidocaine pharmacodynamics pathway , long term potentiation , metoprolol pharmacodynamics pathway , mexiletine pharmacodynamics pathway , mitogen activated protein kinase signaling pathway , nadolol pharmacodynamics pathway , nebivolol pharmacodynamics pathway , nifedipine pharmacodynamics pathway , nimodipine pharmacodynamics pathway , nisoldipine pharmacodynamics pathway , nitrendipine pharmacodynamics pathway , penbutolol pharmacodynamics pathway , phenytoin pharmacodynamics pathway , pindolol pharmacodynamics pathway , procainamide pharmacodynamics pathway , propranolol pharmacodynamics pathway , quinidine pharmacodynamics pathway , sotalol pharmacodynamics pathway , timolol pharmacodynamics pathway , type 2 diabetes mellitus pathway , verapamil pharmacodynamics pathway Cacnb2 arrhythmogenic right ventricular cardiomyopathy pathway , calcium transport pathway , calcium/calcium-mediated signaling pathway , calcium/calmodulin dependent kinase 2 signaling pathway , dilated cardiomyopathy pathway , hypertrophic cardiomyopathy pathway , mitogen activated protein kinase signaling pathway Cacng2 arrhythmogenic right ventricular cardiomyopathy pathway , calcium/calmodulin dependent kinase 2 signaling pathway , dilated cardiomyopathy pathway , hypertrophic cardiomyopathy pathway , mitogen activated protein kinase signaling pathway Calm1 acebutolol pharmacodynamics pathway , adenosine monophosphate-activated protein kinase (AMPK) signaling pathway , adrenergic beta receptor agonist and beta-blocker pharmacodynamics pathway , Alzheimer's disease pathway , amiodarone pharmacodynamics pathway , amlodipine pharmacodynamics pathway , atenolol pharmacodynamics pathway , betaxolol pharmacodynamics pathway , bisoprolol pharmacodynamics pathway , bupranolol drug pathway , bupranolol pharmacodynamics pathway , calcium/calcium-mediated signaling pathway , calcium/calmodulin dependent kinase 2 signaling pathway , carvedilol pharmacodynamics pathway , diltiazem pharmacodynamics pathway , disopyramide pharmacodynamics pathway , dobutamine pharmacodynamics pathway , esmolol pharmacodynamics pathway , flecainde pharmacodynamics pathway , fosphenytoin pharmacodynamics pathway , glioma pathway , glycogen degradation pathway , gonadotropin-releasing hormone signaling pathway , ibutilide pharmacodynamics pathway , insulin responsive facilitative sugar transporter mediated glucose transport pathway , insulin signaling pathway , isoprenaline pharmacodynamics pathway , isradipine pharmacodynamics pathway , levobunolol pharmacodynamics pathway , lidocaine pharmacodynamics pathway , long term potentiation , metoprolol pharmacodynamics pathway , mexiletine pharmacodynamics pathway , N-cadherin signaling pathway , nadolol pharmacodynamics pathway , nebivolol pharmacodynamics pathway , neurotrophic factor signaling pathway , nifedipine pharmacodynamics pathway , nimodipine pharmacodynamics pathway , nisoldipine pharmacodynamics pathway , nitrendipine pharmacodynamics pathway , p38 MAPK signaling pathway , penbutolol pharmacodynamics pathway , phenytoin pharmacodynamics pathway , phosphatidylinositol 3-kinase signaling pathway , pindolol pharmacodynamics pathway , procainamide pharmacodynamics pathway , propranolol pharmacodynamics pathway , quinidine pharmacodynamics pathway , sotalol pharmacodynamics pathway , timolol pharmacodynamics pathway , tuberculosis pathway , type II interferon signaling pathway , vascular endothelial growth factor signaling pathway , verapamil pharmacodynamics pathway , visual phototransduction pathway Calm2 adenosine monophosphate-activated protein kinase (AMPK) signaling pathway , Alzheimer's disease pathway , calcium/calcium-mediated signaling pathway , calcium/calmodulin dependent kinase 2 signaling pathway , glioma pathway , glycogen degradation pathway , gonadotropin-releasing hormone signaling pathway , insulin responsive facilitative sugar transporter mediated glucose transport pathway , insulin signaling pathway , long term potentiation , N-cadherin signaling pathway , neurotrophic factor signaling pathway , p38 MAPK signaling pathway , phosphatidylinositol 3-kinase signaling pathway , tuberculosis pathway , type II interferon signaling pathway , vascular endothelial growth factor signaling pathway , visual phototransduction pathway Calm3 adenosine monophosphate-activated protein kinase (AMPK) signaling pathway , Alzheimer's disease pathway , calcium/calcium-mediated signaling pathway , calcium/calmodulin dependent kinase 2 signaling pathway , glioma pathway , glycogen degradation pathway , gonadotropin-releasing hormone signaling pathway , insulin responsive facilitative sugar transporter mediated glucose transport pathway , insulin signaling pathway , long term potentiation , N-cadherin signaling pathway , neurotrophic factor signaling pathway , p38 MAPK signaling pathway , phosphatidylinositol 3-kinase signaling pathway , tuberculosis pathway , type II interferon signaling pathway , vascular endothelial growth factor signaling pathway , visual phototransduction pathway Camk2a calcium/calcium-mediated signaling pathway , calcium/calmodulin dependent kinase 2 signaling pathway , epidermal growth factor/neuregulin signaling pathway , fibroblast growth factor signaling pathway , glioma pathway , gonadotropin-releasing hormone signaling pathway , long term potentiation , neurotrophic factor signaling pathway , transforming growth factor-beta Smad dependent signaling pathway , tuberculosis pathway , type II interferon signaling pathway , Wnt signaling pathway , Wnt signaling, non-canonical pathway Camk2b calcium/calcium-mediated signaling pathway , calcium/calmodulin dependent kinase 2 signaling pathway , epidermal growth factor/neuregulin signaling pathway , glioma pathway , gonadotropin-releasing hormone signaling pathway , long term potentiation , neurotrophic factor signaling pathway , p38 MAPK signaling pathway , tuberculosis pathway , type II interferon signaling pathway , Wnt signaling pathway Camk2d calcium/calcium-mediated signaling pathway , calcium/calmodulin dependent kinase 2 signaling pathway , epidermal growth factor/neuregulin signaling pathway , glioma pathway , gonadotropin-releasing hormone signaling pathway , long term potentiation , neurotrophic factor signaling pathway , tuberculosis pathway , type II interferon signaling pathway , Wnt signaling pathway Camk2g calcium/calcium-mediated signaling pathway , calcium/calmodulin dependent kinase 2 signaling pathway , epidermal growth factor/neuregulin signaling pathway , glioma pathway , gonadotropin-releasing hormone signaling pathway , long term potentiation , N-cadherin signaling pathway , neurotrophic factor signaling pathway , tuberculosis pathway , type II interferon signaling pathway , Wnt signaling pathway Camk2n1 calcium/calmodulin dependent kinase 2 signaling pathway Camk2n2 calcium/calmodulin dependent kinase 2 signaling pathway Dlg1 acebutolol pharmacodynamics pathway , adrenergic beta receptor agonist and beta-blocker pharmacodynamics pathway , amiodarone pharmacodynamics pathway , amlodipine pharmacodynamics pathway , atenolol pharmacodynamics pathway , betaxolol pharmacodynamics pathway , bisoprolol pharmacodynamics pathway , bupranolol drug pathway , bupranolol pharmacodynamics pathway , calcium/calmodulin dependent kinase 2 signaling pathway , carvedilol pharmacodynamics pathway , diltiazem pharmacodynamics pathway , disopyramide pharmacodynamics pathway , dobutamine pharmacodynamics pathway , E-cadherin signaling pathway , esmolol pharmacodynamics pathway , flecainde pharmacodynamics pathway , fosphenytoin pharmacodynamics pathway , ibutilide pharmacodynamics pathway , isoprenaline pharmacodynamics pathway , isradipine pharmacodynamics pathway , levobunolol pharmacodynamics pathway , lidocaine pharmacodynamics pathway , metoprolol pharmacodynamics pathway , mexiletine pharmacodynamics pathway , nadolol pharmacodynamics pathway , nebivolol pharmacodynamics pathway , nifedipine pharmacodynamics pathway , nimodipine pharmacodynamics pathway , nisoldipine pharmacodynamics pathway , nitrendipine pharmacodynamics pathway , penbutolol pharmacodynamics pathway , phenytoin pharmacodynamics pathway , pindolol pharmacodynamics pathway , procainamide pharmacodynamics pathway , propranolol pharmacodynamics pathway , quinidine pharmacodynamics pathway , sotalol pharmacodynamics pathway , T cell receptor signaling pathway , timolol pharmacodynamics pathway , verapamil pharmacodynamics pathway Gria1 amyotrophic lateral sclerosis pathway , calcium/calmodulin dependent kinase 2 signaling pathway , ephrin - ephrin receptor bidirectional signaling axis , glutamate signaling pathway , long term depression , long term potentiation , Reelin signaling pathway Grin1 alfentanil pharmacodynamics pathway , Alzheimer's disease pathway , amyotrophic lateral sclerosis pathway , bupivacaine pharmacodynamics pathway , buprenorphine pharmacodynamics pathway , calcium/calcium-mediated signaling pathway , calcium/calmodulin dependent kinase 2 signaling pathway , chloroprocaine pharmacodynamics pathway , citalopram pharmacodynamics pathway , cocaine pharmacodynamics pathway , codeine and morphine pharmacodynamics pathway , desipramine pharmacodynamics pathway , diphenoxylate pharmacodynamics pathway , escitalopram pharmacodynamics pathway , ethylmorphine pharmacodynamics pathway , excitatory synaptic transmission pathway , fentanyl pharmacodynamics pathway , fluoxetine pharmacodynamics pathway , glutamate signaling pathway , heroin pharmacodynamics pathway , Huntington's disease pathway , hydrocodone pharmacodynamics pathway , hydromorphone pharmacodynamics pathway , imipramine pharmacodynamics pathway , levacetylmethadol pharmacodynamics pathway , levobupivacaine phgarmacodynamics pathway , levorphanol pharmacodynamics pathway , lidocaine pharmacodynamics pathway , long term potentiation , mepivacaine pharmacodynamics pathway , methadone pharmacodynamics pathway , methadone pharmacokinetics pathway , nalbuphine pharmacodynamics pathway , naloxone pharmacodynamics pathway , naltrexone pharmacodynamics pathway , nicotine pharmacodynamics pathway , oxybuprocaine pharmacodynamics pathway , oxycodone pharmacodynamics pathway , oxymorphone pharmacodynamics pathway , pentazocine pharmacodynamics pathway , prilocaine pharmacodynamics pathway , procaine pharmacodynamics pathway , remifentanil pharmacodynamics pathway , ropivacaine pharmacodynamics pathway , tramadol pharmacodynamics pathway Grin2a alfentanil pharmacodynamics pathway , Alzheimer's disease pathway , amyotrophic lateral sclerosis pathway , bupivacaine pharmacodynamics pathway , buprenorphine pharmacodynamics pathway , calcium/calcium-mediated signaling pathway , calcium/calmodulin dependent kinase 2 signaling pathway , chloroprocaine pharmacodynamics pathway , citalopram pharmacodynamics pathway , cocaine pharmacodynamics pathway , codeine and morphine pharmacodynamics pathway , desipramine pharmacodynamics pathway , diphenoxylate pharmacodynamics pathway , escitalopram pharmacodynamics pathway , ethylmorphine pharmacodynamics pathway , excitatory synaptic transmission pathway , fentanyl pharmacodynamics pathway , fluoxetine pharmacodynamics pathway , glutamate signaling pathway , heroin pharmacodynamics pathway , hydrocodone pharmacodynamics pathway , hydromorphone pharmacodynamics pathway , imipramine pharmacodynamics pathway , levacetylmethadol pharmacodynamics pathway , levobupivacaine phgarmacodynamics pathway , levorphanol pharmacodynamics pathway , lidocaine pharmacodynamics pathway , long term depression , long term potentiation , mepivacaine pharmacodynamics pathway , methadone pharmacodynamics pathway , methadone pharmacokinetics pathway , nalbuphine pharmacodynamics pathway , naloxone pharmacodynamics pathway , naltrexone pharmacodynamics pathway , nicotine pharmacodynamics pathway , oxybuprocaine pharmacodynamics pathway , oxycodone pharmacodynamics pathway , oxymorphone pharmacodynamics pathway , pentazocine pharmacodynamics pathway , prilocaine pharmacodynamics pathway , procaine pharmacodynamics pathway , Reelin signaling pathway , remifentanil pharmacodynamics pathway , ropivacaine pharmacodynamics pathway , systemic lupus erythematosus pathway , tramadol pharmacodynamics pathway Grin2b Alzheimer's disease pathway , amyotrophic lateral sclerosis pathway , calcium/calmodulin dependent kinase 2 signaling pathway , excitatory synaptic transmission pathway , glutamate signaling pathway , Huntington's disease pathway , long term potentiation , Reelin signaling pathway , systemic lupus erythematosus pathway Hdac4 calcium/calmodulin dependent kinase 2 signaling pathway , histone modification pathway Hdac5 calcium/calmodulin dependent kinase 2 signaling pathway , histone modification pathway Lrrc7 calcium/calmodulin dependent kinase 2 signaling pathway Pln acebutolol pharmacodynamics pathway , adrenergic beta receptor agonist and beta-blocker pharmacodynamics pathway , amiodarone pharmacodynamics pathway , amlodipine pharmacodynamics pathway , atenolol pharmacodynamics pathway , betaxolol pharmacodynamics pathway , bisoprolol pharmacodynamics pathway , bupranolol drug pathway , bupranolol pharmacodynamics pathway , calcium/calcium-mediated signaling pathway , calcium/calmodulin dependent kinase 2 signaling pathway , carvedilol pharmacodynamics pathway , dilated cardiomyopathy pathway , diltiazem pharmacodynamics pathway , disopyramide pharmacodynamics pathway , dobutamine pharmacodynamics pathway , esmolol pharmacodynamics pathway , flecainde pharmacodynamics pathway , fosphenytoin pharmacodynamics pathway , ibutilide pharmacodynamics pathway , isoprenaline pharmacodynamics pathway , isradipine pharmacodynamics pathway , levobunolol pharmacodynamics pathway , lidocaine pharmacodynamics pathway , metoprolol pharmacodynamics pathway , mexiletine pharmacodynamics pathway , nadolol pharmacodynamics pathway , nebivolol pharmacodynamics pathway , nifedipine pharmacodynamics pathway , nimodipine pharmacodynamics pathway , nisoldipine pharmacodynamics pathway , nitrendipine pharmacodynamics pathway , penbutolol pharmacodynamics pathway , phenytoin pharmacodynamics pathway , pindolol pharmacodynamics pathway , procainamide pharmacodynamics pathway , propranolol pharmacodynamics pathway , quinidine pharmacodynamics pathway , sotalol pharmacodynamics pathway , timolol pharmacodynamics pathway , verapamil pharmacodynamics pathway Ppm1e adenosine monophosphate-activated protein kinase (AMPK) signaling pathway , calcium/calmodulin dependent kinase 2 signaling pathway Ppm1f adenosine monophosphate-activated protein kinase (AMPK) signaling pathway , calcium/calmodulin dependent kinase 2 signaling pathway Ppp1cc calcium/calmodulin dependent kinase 2 signaling pathway , dopamine signaling pathway , glycogen biosynthetic pathway , glycogen degradation pathway , insulin responsive facilitative sugar transporter mediated glucose transport pathway , insulin signaling pathway , long term potentiation Ppp2ca adenosine monophosphate-activated protein kinase (AMPK) signaling pathway , ataxia telangiectasia-mutated (ATM) signaling pathway , calcium/calmodulin dependent kinase 2 signaling pathway , Chagas disease pathway , dopamine signaling pathway , hepatitis C pathway , long term depression , mRNA decay pathway , p53 signaling pathway , phosphatidylinositol 3-kinase-Akt signaling pathway , platelet-derived growth factor signaling pathway , transforming growth factor-beta Smad dependent signaling pathway , transforming growth factor-beta superfamily mediated signaling pathway , Wnt signaling pathway Ryr2 acebutolol pharmacodynamics pathway , adrenergic beta receptor agonist and beta-blocker pharmacodynamics pathway , amiodarone pharmacodynamics pathway , amlodipine pharmacodynamics pathway , arrhythmogenic right ventricular cardiomyopathy pathway , atenolol pharmacodynamics pathway , betaxolol pharmacodynamics pathway , bisoprolol pharmacodynamics pathway , bupranolol drug pathway , bupranolol pharmacodynamics pathway , calcium transport pathway , calcium/calcium-mediated signaling pathway , calcium/calmodulin dependent kinase 2 signaling pathway , carvedilol pharmacodynamics pathway , dilated cardiomyopathy pathway , diltiazem pharmacodynamics pathway , disopyramide pharmacodynamics pathway , dobutamine pharmacodynamics pathway , esmolol pharmacodynamics pathway , flecainde pharmacodynamics pathway , fosphenytoin pharmacodynamics pathway , hypertrophic cardiomyopathy pathway , ibutilide pharmacodynamics pathway , isoprenaline pharmacodynamics pathway , isradipine pharmacodynamics pathway , levobunolol pharmacodynamics pathway , lidocaine pharmacodynamics pathway , metoprolol pharmacodynamics pathway , mexiletine pharmacodynamics pathway , nadolol pharmacodynamics pathway , nebivolol pharmacodynamics pathway , nifedipine pharmacodynamics pathway , nimodipine pharmacodynamics pathway , nisoldipine pharmacodynamics pathway , nitrendipine pharmacodynamics pathway , penbutolol pharmacodynamics pathway , phenytoin pharmacodynamics pathway , pindolol pharmacodynamics pathway , procainamide pharmacodynamics pathway , propranolol pharmacodynamics pathway , quinidine pharmacodynamics pathway , sotalol pharmacodynamics pathway , timolol pharmacodynamics pathway , verapamil pharmacodynamics pathway Scn5a acebutolol pharmacodynamics pathway , adrenergic beta receptor agonist and beta-blocker pharmacodynamics pathway , amiodarone pharmacodynamics pathway , amlodipine pharmacodynamics pathway , atenolol pharmacodynamics pathway , betaxolol pharmacodynamics pathway , bisoprolol pharmacodynamics pathway , bupranolol drug pathway , bupranolol pharmacodynamics pathway , calcium/calmodulin dependent kinase 2 signaling pathway , carvedilol pharmacodynamics pathway , diltiazem pharmacodynamics pathway , disopyramide pharmacodynamics pathway , dobutamine pharmacodynamics pathway , esmolol pharmacodynamics pathway , flecainde pharmacodynamics pathway , fosphenytoin pharmacodynamics pathway , fosphenytoin pharmacokinetics pathway , ibutilide pharmacodynamics pathway , isoprenaline pharmacodynamics pathway , isradipine pharmacodynamics pathway , levobunolol pharmacodynamics pathway , lidocaine pharmacodynamics pathway , metoprolol pharmacodynamics pathway , mexiletine pharmacodynamics pathway , nadolol pharmacodynamics pathway , nebivolol pharmacodynamics pathway , nifedipine pharmacodynamics pathway , nimodipine pharmacodynamics pathway , nisoldipine pharmacodynamics pathway , nitrendipine pharmacodynamics pathway , penbutolol pharmacodynamics pathway , phenytoin pharmacodynamics pathway , pindolol pharmacodynamics pathway , procainamide pharmacodynamics pathway , propranolol pharmacodynamics pathway , quinidine pharmacodynamics pathway , sotalol pharmacodynamics pathway , timolol pharmacodynamics pathway , verapamil pharmacodynamics pathway Syngap1 calcium/calmodulin dependent kinase 2 signaling pathway
acebutolol pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a adenosine monophosphate-activated protein kinase (AMPK) signaling pathway Calm1 , Calm2 , Calm3 , Ppm1e , Ppm1f , Ppp2ca adrenergic beta receptor agonist and beta-blocker pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a alfentanil pharmacodynamics pathway Grin1 , Grin2a Alzheimer's disease pathway Cacna1c , Calm1 , Calm2 , Calm3 , Grin1 , Grin2a , Grin2b amiodarone pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a amlodipine pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a amyotrophic lateral sclerosis pathway Gria1 , Grin1 , Grin2a , Grin2b arrhythmogenic right ventricular cardiomyopathy pathway Cacna1c , Cacnb2 , Cacng2 , Ryr2 ataxia telangiectasia-mutated (ATM) signaling pathway Ppp2ca atenolol pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a betaxolol pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a bisoprolol pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a bupivacaine pharmacodynamics pathway Grin1 , Grin2a bupranolol drug pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a bupranolol pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a buprenorphine pharmacodynamics pathway Grin1 , Grin2a calcium transport pathway Cacna1c , Cacnb2 , Ryr2 calcium/calcium-mediated signaling pathway Cacna1c , Cacnb2 , Calm1 , Calm2 , Calm3 , Camk2a , Camk2b , Camk2d , Camk2g , Grin1 , Grin2a , Pln , Ryr2 calcium/calmodulin dependent kinase 2 signaling pathway Cacna1c , Cacnb2 , Cacng2 , Calm1 , Calm2 , Calm3 , Camk2a , Camk2b , Camk2d , Camk2g , Camk2n1 , Camk2n2 , Dlg1 , Gria1 , Grin1 , Grin2a , Grin2b , Hdac4 , Hdac5 , Lrrc7 , Pln , Ppm1e , Ppm1f , Ppp1cc , Ppp2ca , Ryr2 , Scn5a , Syngap1 carvedilol pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a Chagas disease pathway Ppp2ca chloroprocaine pharmacodynamics pathway Grin1 , Grin2a citalopram pharmacodynamics pathway Grin1 , Grin2a cocaine pharmacodynamics pathway Grin1 , Grin2a codeine and morphine pharmacodynamics pathway Grin1 , Grin2a desipramine pharmacodynamics pathway Grin1 , Grin2a dilated cardiomyopathy pathway Cacna1c , Cacnb2 , Cacng2 , Pln , Ryr2 diltiazem pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a diphenoxylate pharmacodynamics pathway Grin1 , Grin2a disopyramide pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a dobutamine pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a dopamine signaling pathway Ppp1cc , Ppp2ca E-cadherin signaling pathway Dlg1 ephrin - ephrin receptor bidirectional signaling axis Gria1 epidermal growth factor/neuregulin signaling pathway Camk2a , Camk2b , Camk2d , Camk2g escitalopram pharmacodynamics pathway Grin1 , Grin2a esmolol pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a ethylmorphine pharmacodynamics pathway Grin1 , Grin2a excitatory synaptic transmission pathway Grin1 , Grin2a , Grin2b felodipine pharmacokinetics pathway Cacna1c fentanyl pharmacodynamics pathway Grin1 , Grin2a fibroblast growth factor signaling pathway Camk2a flecainde pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a fluoxetine pharmacodynamics pathway Grin1 , Grin2a fosphenytoin pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a fosphenytoin pharmacokinetics pathway Scn5a glioma pathway Calm1 , Calm2 , Calm3 , Camk2a , Camk2b , Camk2d , Camk2g glutamate signaling pathway Cacna1c , Gria1 , Grin1 , Grin2a , Grin2b glycogen biosynthetic pathway Ppp1cc glycogen degradation pathway Calm1 , Calm2 , Calm3 , Ppp1cc gonadotropin-releasing hormone signaling pathway Cacna1c , Calm1 , Calm2 , Calm3 , Camk2a , Camk2b , Camk2d , Camk2g hepatitis C pathway Ppp2ca heroin pharmacodynamics pathway Grin1 , Grin2a histone modification pathway Hdac4 , Hdac5 Huntington's disease pathway Grin1 , Grin2b hydrocodone pharmacodynamics pathway Grin1 , Grin2a hydromorphone pharmacodynamics pathway Grin1 , Grin2a hypertrophic cardiomyopathy pathway Cacna1c , Cacnb2 , Cacng2 , Ryr2 ibutilide pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a imipramine pharmacodynamics pathway Grin1 , Grin2a insulin responsive facilitative sugar transporter mediated glucose transport pathway Calm1 , Calm2 , Calm3 , Ppp1cc insulin secretion pathway Cacna1c insulin signaling pathway Calm1 , Calm2 , Calm3 , Ppp1cc isoprenaline pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a isradipine pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a levacetylmethadol pharmacodynamics pathway Grin1 , Grin2a levobunolol pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a levobupivacaine phgarmacodynamics pathway Grin1 , Grin2a levorphanol pharmacodynamics pathway Grin1 , Grin2a lidocaine pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Grin1 , Grin2a , Pln , Ryr2 , Scn5a long term depression Gria1 , Grin2a , Ppp2ca long term potentiation Cacna1c , Calm1 , Calm2 , Calm3 , Camk2a , Camk2b , Camk2d , Camk2g , Gria1 , Grin1 , Grin2a , Grin2b , Ppp1cc mepivacaine pharmacodynamics pathway Grin1 , Grin2a methadone pharmacodynamics pathway Grin1 , Grin2a methadone pharmacokinetics pathway Grin1 , Grin2a metoprolol pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a mexiletine pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a mitogen activated protein kinase signaling pathway Cacna1c , Cacnb2 , Cacng2 mRNA decay pathway Ppp2ca N-cadherin signaling pathway Calm1 , Calm2 , Calm3 , Camk2g nadolol pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a nalbuphine pharmacodynamics pathway Grin1 , Grin2a naloxone pharmacodynamics pathway Grin1 , Grin2a naltrexone pharmacodynamics pathway Grin1 , Grin2a nebivolol pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a neurotrophic factor signaling pathway Calm1 , Calm2 , Calm3 , Camk2a , Camk2b , Camk2d , Camk2g nicotine pharmacodynamics pathway Grin1 , Grin2a nifedipine pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a nimodipine pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a nisoldipine pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a nitrendipine pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a oxybuprocaine pharmacodynamics pathway Grin1 , Grin2a oxycodone pharmacodynamics pathway Grin1 , Grin2a oxymorphone pharmacodynamics pathway Grin1 , Grin2a p38 MAPK signaling pathway Calm1 , Calm2 , Calm3 , Camk2b p53 signaling pathway Ppp2ca penbutolol pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a pentazocine pharmacodynamics pathway Grin1 , Grin2a phenytoin pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a phosphatidylinositol 3-kinase signaling pathway Calm1 , Calm2 , Calm3 phosphatidylinositol 3-kinase-Akt signaling pathway Ppp2ca pindolol pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a platelet-derived growth factor signaling pathway Ppp2ca prilocaine pharmacodynamics pathway Grin1 , Grin2a procainamide pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a procaine pharmacodynamics pathway Grin1 , Grin2a propranolol pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a quinidine pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a Reelin signaling pathway Gria1 , Grin2a , Grin2b remifentanil pharmacodynamics pathway Grin1 , Grin2a ropivacaine pharmacodynamics pathway Grin1 , Grin2a sotalol pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a systemic lupus erythematosus pathway Grin2a , Grin2b T cell receptor signaling pathway Dlg1 timolol pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a tramadol pharmacodynamics pathway Grin1 , Grin2a transforming growth factor-beta Smad dependent signaling pathway Camk2a , Ppp2ca transforming growth factor-beta superfamily mediated signaling pathway Ppp2ca tuberculosis pathway Calm1 , Calm2 , Calm3 , Camk2a , Camk2b , Camk2d , Camk2g type 2 diabetes mellitus pathway Cacna1c type II interferon signaling pathway Calm1 , Calm2 , Calm3 , Camk2a , Camk2b , Camk2d , Camk2g vascular endothelial growth factor signaling pathway Calm1 , Calm2 , Calm3 verapamil pharmacodynamics pathway Cacna1c , Calm1 , Dlg1 , Pln , Ryr2 , Scn5a visual phototransduction pathway Calm1 , Calm2 , Calm3 Wnt signaling pathway Camk2a , Camk2b , Camk2d , Camk2g , Ppp2ca Wnt signaling, non-canonical pathway Camk2a
Phenotype Annotations Associated with Genes in the calcium/calmodulin dependent kinase 2 signaling pathway
Cacna1c abnormal social play behavior , abnormal vocalization , cognitive inflexibility , decreased vertical activity , impaired spatial learning , increased grooming behavior Camk2d seizures Camk2n1 decreased brown adipose tissue mass , decreased epididymal fat pad weight , decreased heart left ventricle weight , decreased mesenteric fat pad weight , decreased retroperitoneal fat pad weight , decreased systemic arterial diastolic blood pressure , decreased systemic arterial systolic blood pressure Grin2a abnormal drug-induced reinstatement of an extinguished operant behavior for a drug reinforcer , increased susceptibility to ischemic brain injury
References Associated with the calcium/calmodulin dependent kinase 2 signaling pathway:
Lisman J, etal., Nat Rev Neurosci. 2012 Feb 15;13(3):169-82. doi: 10.1038/nrn3192.
Coultrap SJ and Bayer KU, Trends Neurosci. 2012 Oct;35(10):607-18. doi: 10.1016/j.tins.2012.05.003. Epub 2012 Jun 19.
Lucchesi W, etal., Brain Res Bull. 2011 Apr 25;85(1-2):2-8. doi: 10.1016/j.brainresbull.2010.10.009. Epub 2010 Nov 9.
Skelding KA, etal., Cell Cycle. 2011 Feb 15;10(4):631-9. Epub 2011 Feb 15.
Rokita AG and Anderson ME, Circulation. 2012 Oct 23;126(17):2125-39. doi: 10.1161/CIRCULATIONAHA.112.124990.
Bers DM Heart Rhythm. 2011 Jul;8(7):1101-4. doi: 10.1016/j.hrthm.2011.01.030. Epub 2011 Jan 18.
Ishida A, etal., Br J Pharmacol. 2008 Jun;154(4):729-40. doi: 10.1038/bjp.2008.127. Epub 2008 May 5.
Chao LH, etal., Cell. 2011 Sep 2;146(5):732-45. doi: 10.1016/j.cell.2011.07.038.
Rellos P, etal., PLoS Biol. 2010 Jul 27;8(7):e1000426. doi: 10.1371/journal.pbio.1000426.
Tombes RM, etal., Gene. 2003 Dec 11;322:17-31.
Sanhueza M and Lisman J, Mol Brain. 2013 Feb 14;6(1):10.
Liu XB and Murray KD, Epilepsia. 2012 Jun;53 Suppl 1:45-52. doi: 10.1111/j.1528-1167.2012.03474.x.
Erickson JR, etal., Physiol Rev. 2011 Jul;91(3):889-915. doi: 10.1152/physrev.00018.2010.
Cerra MC and Imbrogno S, Acta Physiol (Oxf). 2012 May;205(1):9-25. doi: 10.1111/j.1748-1716.2012.02389.x.
Bers DM and Grandi E, J Cardiovasc Pharmacol. 2009 Sep;54(3):180-7. doi: 10.1097/FJC.0b013e3181a25078.
Swaminathan PD, etal., Circ Res. 2012 Jun 8;110(12):1661-77. doi: 10.1161/CIRCRESAHA.111.243956.
Ontology Path Diagram:
Import into Pathway Studio: